Cancer Institute Says Paused Pediatric Brain Tumor Trials May Reopen in Late 2026

This Cancer Kills Children in a Year. Research Has Been Stalled for a Year.

nytimes.com· · 6d
Open

A New York Times feature reports that in August 2025 the National Cancer Institute terminated the Pediatric Brain Tumor Consortium, a 16-hospital collaboration that was the cornerstone of federal pediatric brain cancer research, by not renewing its $4 million annual grant, closing or pausing eight clinical trials for D.I.P.G., an incurable brainstem tumor that strikes about 300 American children a year and kills within nine to 12 months. The story follows 5-year-old Ryleigh Schecter of Ohio, whose experimental drug regimen was in a consortium-linked trial, and parents whose children died of the disease, like Baylie Barclay, who lost her son Paxton in July 2025. Consortium chair Ira Dunkel called the news 'catastrophic' and said the official delivering it would not say who decided. The institute says the closure was a consolidation, not a cost-cutting measure, and says the paused trials are planned to reopen in late 2026 or early 2027, a delay parents find agonizing for children who have a year or less to live.

Sign in with subscription

Free during the beta.

Clear all notifications?

Your bells stay on. Only this list empties.